Misfit Alpha

Misfit Alpha

Share this post

Misfit Alpha
Misfit Alpha
Intriguing IPOS? Lineage (LINE) and Concentra Group Holdings (CON)

Intriguing IPOS? Lineage (LINE) and Concentra Group Holdings (CON)

Two IPOs this week worth cracking open the S-1s

Misfit Alpha's avatar
Misfit Alpha
Jul 23, 2024
∙ Paid

Share this post

Misfit Alpha
Misfit Alpha
Intriguing IPOS? Lineage (LINE) and Concentra Group Holdings (CON)
Share
Study in a Wood, Daniel Huntington, 1861, oil on canvas (Metropolitan Museum of Art)

The IPO market has been a little quieter in recent weeks. Or, at least from my perspective, there haven’t been any companies worth going past the business description section.

(side note: I’ll wholly admit that a few pre-clinical trial drug companies IPOd, and I have no idea if they are worth time and attention. Startup drug companies and banks remain languages I cannot speak).

This week, two companies intend to IPO that have a lot of surface appeal. Some would argue that a third company, OneStream (NASDAQ: OS), is a worthy candidate. However, I’m less confident that the public market needs yet another private-equity-backed, unprofitable B2B SaaS company shoved down its throat. So let’s save our energy for two: Lineage (NASDAQ: LINE) and Concerta Group Holdings Parent, Inc. (NYSE: CON). Here’s a knee-jerk reaction to both prospectuses.


Shoutout to Koyfin for their data and charts. Koyfin has become an integral part of how I screen for, track, and analyze companies. It has made the analysis process much faster thanks to having a decade of data at my fingertips instead of manually going through stacks of quarterly and annual filings.

Up your analysis process by Signing up for Koyfin. Click on the link below and receive 10% off your annual subscription.

Claim my 10% off Koyfin now!

Disclaimer: I have an affiliate partnership with Koyfin and receive compensation if you sign up via the link above. It helps me fund this endeavor. I would still recommend using it even if I didn’t have this partnership because it’s an awesome product, but I’d be stupid to turn down a revenue opportunity. You get a discount, Koyfin gets new business, and I get a commission. Win-win-win).

Keep reading with a 7-day free trial

Subscribe to Misfit Alpha to keep reading this post and get 7 days of free access to the full post archives.

Already a paid subscriber? Sign in
© 2025 Misfit Alpha
Privacy ∙ Terms ∙ Collection notice
Start writingGet the app
Substack is the home for great culture

Share